Fernando Riesgo-Gil

Fernando Riesgo-Gil

Auto-generated profile, based on publicly available information

Fernando Riesgo-Gil

Royal Brompton and Harefield Hospitals, Guy’s and St Thomas’ NHS Foundation Trust, London, UK

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Surgical Oncology
Verified
Journal Article
Closed access
MMMaría Monteagudo-Vela
María Monteagudo-Vela
FRFernando Riesgo-Gil
Fernando Riesgo-Gil
HSHassiba Smail
Hassiba Smail
DGDiana García-Saez
Diana García-Saez
BHBass Hassan
Bass Hassan
ASAndré Simon
André Simon

12 December 2025 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
NMNikolaos Miaris
Nikolaos Miaris
HRHusein Rajabali
Husein Rajabali
NQNicholas M Quaife
Nicholas M Quaife
FGFernando Riesgo Gil
Fernando Riesgo Gil
ODOwais Dar
Owais Dar
JWJoyce Wong
Joyce Wong
Cardiovascular magnetic resonance (CMR) has been studied as an alternative to endomyocardial biopsy (EMB) in orthotopic heart transplant recipients (OHTRs), particularly through breath-hold myocardial T1 and T2 mapping sequences. We aimed to assess the diagnostic performance of the novel free-breathing multiparametric saturation-recovery single-shot acquisition (mSASHA) mapping technique to identify acute cardiac allograft rejection (ACAR) non-invasively against EMB. This retrospective study included n = 21 consecutive OHTRs with suspected ACAR who underwent both a 1.5T CMR scan with mSASHA mapping and an EMB within 5.4 (1.2–14.8) days, and n = 20 healthy controls who underwent CMR with mSASHA mapping. Conventional breath-holding T2-prepared balanced steady-state free precession (T2p-bSSFP) T2 mapping was also acquired. CAR was EMB defined as histological rejection (HR) (acute cellular rejection of ≥ 1 R or acute antibody-mediated rejection of ≥ 1). Overall, n = 21 OHTRs (9 females) with a mean age of 43.2 ± 16.2 years and a median time of 5.4 (1.2–14.8) years since transplantation were included in the study, alongside n = 20 healthy controls. HR was present in n = 9 patients. The HR group showed significantly higher septal mSASHA T2 values compared to the non-HR ( n = 12) group (53 ± 6 ms vs. 47 ± 4 ms, p = 0.014). Receiver operator characteristics analysis showed an area under the curve of 0.79 (95% confidence interval 0.59–0.98, p = 0.028) and an optimal cut-off value of 50 ms (sensitivity of 67%, specificity of 75%) for identifying patients with HR using septal mSASHA T2 values. There was at least a moderate correlation of septal and global mSASHA T1 and T2 values ( n = 21) with MOLLI T1 ( n = 17) and T2p-bSSFP T2 ( n = 18) values ( r > 0.6, p ≤ 0.003). OHTR patients without HR showed higher septal (T1: 1256 ± 42 ms vs. 1201 ± 46 ms, p = 0.002; T2: 47 ± 4 ms vs. 43 ± 2 ms, p = 0.003) and global mSASHA (T1: 1250 ± 58 ms vs. 1201 ± 45 ms, p = 0.013; T2: 48 ± 5 ms vs. 43 ± 2 ms, p = 0.009) values compared to normal controls ( n = 20). In the control group, native mSASHA T1 and T2 values were higher in females ( n = 9) than in males. Free-breathing mSASHA T2 mapping may be useful in identifying histological changes associated with ACAR, overcoming the challenges of breath holding and with good diagnostic performance.

1 May 2025 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Closed access
ILIsabella Leo
Isabella Leo
GBGiandomenico Bisaccia
Giandomenico Bisaccia
JWJoyce Wong
Joyce Wong
FRFernando Riesgo-Gil
Fernando Riesgo-Gil
PKPeter Kellman
Peter Kellman
CBChiara Bucciarelli-Ducci
Chiara Bucciarelli-Ducci

21 October 2025 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
MMMaría De Miguel
María De Miguel
COCorry O’sUllivan
Corry O’sUllivan
CVChristophe Vandenbriele
Christophe Vandenbriele
MOMohamed Osman
Mohamed Osman
FRFernando Riesgo-Gil
Fernando Riesgo-Gil
Background: Temporary mechanical circulatory support (tMCS) is a life-saving intervention in cardiogenic shock (CS), though not without risks. Increasing attention has been given to ventricular unloading and its role in myocardial recovery, particularly in reversible cardiomyopathies. Case summary: A 35-year-old man presenting with CS was initially treated with veno-arterial extracorporeal membrane oxygenation (V-A ECMO) and Impella (ECPELLA). Due to complications, support was escalated to Levitronix biventricular assist device. After 5 months of support and optimized medical therapy, substantial myocardial recovery enabled weaning from MCS and successful hospital discharge. Discussion: MCS provides critical time to investigate the underlying cause of CS and assess the potential for recovery. This case illustrates how MCS can be both life-saving and a platform for ventricular unloading and neurohormonal optimization. Although full recovery is rare in severe cases, such strategies may improve cardiac function and enable successful weaning from support.